Good question. his resume is pretty good.
he specialises in CR's for medical companies and has experience in getting at least 2 medical companies to takeover bids. he was also the sales VP for a company that was purchased by Boston for $26billion where his portfolio was responsible for at least a $1billion of yearly revenue. so, I say they is necessary
Ann: Annual Report to shareholders, page-3
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.20 |
Change
0.350(1.86%) |
Mkt cap ! $369.0M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.20 | $18.52 | $181.1K | 9.632K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1250 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.45 | 106 | 1 |
View Market Depth
| Last trade - 15.11pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.75 |
Change
0.350 ( 0.48 %) |
||||
| Open | High | Low | Volume | ||
| $19.02 | $19.02 | $18.52 | 545 | ||
| Last updated 14.26pm 28/05/2024 ? | |||||
| AVR (ASX) Chart |